KBU2046
CAS No. 1143863-69-7
KBU2046( KBU 2046 | KBU-2046 )
Catalog No. M10511 CAS No. 1143863-69-7
KBU2046 (KBU-2046) is a highly selective inhibitor of metastasis, binds to and stabilizes CDC37/HSP90β heterocomplexes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 72 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 215 | Get Quote |
|
| 50MG | 335 | Get Quote |
|
| 100MG | 507 | Get Quote |
|
| 500MG | 1062 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKBU2046
-
NoteResearch use only, not for human use.
-
Brief DescriptionKBU2046 (KBU-2046) is a highly selective inhibitor of metastasis, binds to and stabilizes CDC37/HSP90β heterocomplexes.
-
DescriptionKBU2046 (KBU-2046) is a highly selective inhibitor of metastasis, binds to and stabilizes CDC37/HSP90β heterocomplexes; selectively disrupts heterocomplex function and inhibits cancer cell motility, only binds to HSP90β and CDC37 when both proteins are present, does not bind to either protein alone; decreases phosphorylation of HSP90β, inhibits cancer metastasis and prolongs life in vivo; KBU2046-mediated changes in the signature of client proteins bound to the HSP90β/CDC37 heterocomplex mediate effects upon cell motility.
-
In Vitro——
-
In Vivo——
-
SynonymsKBU 2046 | KBU-2046
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1143863-69-7
-
Formula Weight242.249
-
Molecular FormulaC15H11FO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (206.40 mM)
-
SMILESO=C1C(C2=CC=C(F)C=C2)COC3=C1C=CC=C3
-
Chemical Name3-(4-fluorophenyl)chroman-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu L, et al. Nat Commun. 2018 Jun 22;9(1):2454.
molnova catalog
related products
-
KUNB 31
KUNB 31 is a potent, isoform-selective Hsp90β inhibitor with Kd of 0.18 uM.
-
AMP-PCP
AMP-PCP is an ATP analogue and can bind to Hsp90 N-terminal domain with a Kd value of 3.8 μM. AMP-PCP binding favors the formation of the active homodimer of Hsp90.
-
Arimoclomol
Arimoclomol is a co-inducer of heat shock proteins (HSP) and can be used in studies about the treatment of amyotrophic lateral sclerosis (ALS).
Cart
sales@molnova.com